TABLE 5.

EGFR antibody for active targeting of nanoparticle drug delivery systems.

Types	PDI	Zeta potential (mV)	Size (nm)
ECMI Zhang et al. (2019)	0.41 ± 0.03	−18.5 ± 1.7	220.0 ± 3.5
Dox-EGF-PEAL NPs	0.182	3.5 ± 0.88	203.7 ± 7.42
Bcl-2-EGF-PEAL NPs Zhang et al. (2016)	0.217	2.1 ± 1.24	206.5 ± 6.37
AP/ES Lv et al. (2018)	0.27 ± 0.01	12.1 ± 0.1	383.1 ± 0.4